aTyr Pharma, Inc. Share Price
ATYRaTyr Pharma, Inc. Stock Performance
Open $0.84 | Prev. Close $0.88 | Circuit Range N/A |
Day Range $0.82 - $0.91 | Year Range $0.64 - $7.29 | Volume 30,153 |
Average Traded $0.85 |
aTyr Pharma, Inc. Share Price Chart
About aTyr Pharma, Inc.
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of product candidates that translate tRNA synthetase biology into new therapies for fibrosis and inflammation in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase 3 clinical trial for the treatment of pulmonary sarcoidosis; and in Phase 1b/2a clinical trial to treat other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical development for the treatment fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
aTyr Pharma, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $0.84 | $0.90 | +9.95% |
05-Feb-26 | $0.86 | $0.81 | -7.81% |
04-Feb-26 | $0.96 | $0.88 | -8.02% |
03-Feb-26 | $0.99 | $0.96 | -1.23% |
02-Feb-26 | $0.88 | $0.97 | +12.11% |
30-Jan-26 | $0.84 | $0.87 | +3.34% |
29-Jan-26 | $0.80 | $0.84 | +25.22% |
FAQs on aTyr Pharma, Inc. Share Price
Can I buy aTyr Pharma, Inc. shares in India?
What is the share price of aTyr Pharma, Inc.?
What is the 5 year returns of aTyr Pharma, Inc.?
What are the high & low stock price of aTyr Pharma, Inc. today?
What is the 52-week high and low of aTyr Pharma, Inc. stock?